Viola Heinzelmann-Schwarz

No ORCID on file · 7 papers in corpus
observational 2026
Frontiers in endocrinology ·doi:10.3389/fendo.2026.1893897

INTRODUCTION: The influence of physical activity on outcomes of assisted reproductive technology (ART) remains incompletely understood, with conflicting evidence regarding the impact of exercise intensity and frequency. This study aimed to …

guideline 2025
Archives of gynecology and obstetrics ·doi:10.1007/s00404-025-07974-z

Opportunistic salpingectomy is defined as the removal of both fallopian tubes as part of a surgical procedure planned for other reasons. The goal is primary prevention of ovarian cancer. The procedure is offered to patients who are not know…

observational 2024
Advances in urology ·doi:10.1155/2024/5568010

INTRODUCTION: Women with lower urinary tract symptoms (LUTS) and high-tone pelvic floor often experience pain and have positive trigger points upon pelvic floor examination. However, the correlation of these findings has not yet been system…

other 2022
Journal of robotic surgery ·doi:10.1007/s11701-021-01209-4

Main aim of this study is to assess the effect of a structured, interdisciplinary, surgical, team-training protocol in robotic gynecologic surgery, with the gradual integration of an advanced nurse practitioner. Data from all robotic surgic…

other 2019
Molecular & cellular proteomics : MCP ·doi:10.1074/mcp.ra118.001221

Protein biomarkers for epithelial ovarian cancer are critical for the early detection of the cancer to improve patient prognosis and for the clinical management of the disease to monitor treatment response and to detect recurrences. Unfortu…

diagnostic-accuracy 2012
International journal of cancer ·doi:10.1002/ijc.26002

Epithelial ovarian cancer has the highest mortality rate among gynecological cancers. Altered glycosylation is associated with oncogenic transformation producing tumor-associated carbohydrate antigens. We investigated the potential of natur…

diagnostic-accuracy 2011
Gynecologic Oncology ·doi:10.1016/j.ygyno.2011.02.022

OBJECTIVE: About 70% of epithelial ovarian cancer patients (EOC) are diagnosed at advanced stage with a five-year survival rate of only 30%. Whilst CA125 detects peritoneally-spread disease, it has limited sensitivity for early cancers, man…